News

Filter

Current filters:

Pramipexole

1 to 9 of 67 results

Boehringer Ingelheim’s prolonged-release Mirapexin/Sifrol gets EU clearance for Parkinson’s disease

15-10-2009

Independent German drug major Boehringer Ingelheim’s Mirapexin/Sifrol (pramipexole) new prolonged-release,…

Boehringer IngelheimEuropeMirapexNeurologicalPharmaceuticalPramipexole

Boeh Ing's Sifrol shows value in PD depression

05-05-2009

Germany's Boehringer Ingleheim presented results demonstrating that Mirapexin/Sifrol (pramipexole) improves…

DopamineDopamine HydrochlorideMirapexPramipexole

Prolonged-release Sifrol shows promise for Boeh Ing

05-05-2009

First data showing outcomes of two double-blind studies investigating the efficacy, safety and tolerability…

MirapexPramipexole

Boeh Ing RLS drug comparable to placebo

05-05-2009

New data presented at the annual meeting of the American Academy of Neurology, in Seattle, Washington,…

MirapexPramipexole

1 to 9 of 67 results

COMPANY SPOTLIGHT

Menarini

Back to top